Home/Filings/4/0001209191-22-047928
4//SEC Filing

Kashmolah Ghazi 4

Accession 0001209191-22-047928

CIK 0001652724other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 8:19 PM ET

Size

4.8 KB

Accession

0001209191-22-047928

Insider Transaction Report

Form 4
Period: 2022-08-25
Kashmolah Ghazi
Ex. VP &Chief Quality Officer
Transactions
  • Sale

    Common Stock

    2022-08-25$1.93/sh1,500$2,895184,677 total
Footnotes (1)
  • [F1]Includes 5,420 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 19, 2022.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001877741

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 8:19 PM ET
Size
4.8 KB